Savendahl, L., Højby Rasmussen, M., Horikawa, R., Khadilkar, V., Battelino, T., & Saenger, P. (2019). SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3). J Endocr Soc.
Chicago Style CitationSavendahl, Lars, Michael Højby Rasmussen, Reiko Horikawa, Vaman Khadilkar, Tadej Battelino, i Paul Saenger. "SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)." J Endocr Soc 2019.
Cita MLASavendahl, Lars, et al. "SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)." J Endocr Soc 2019.